APA (7th ed.) Citation

Xajil-Ramos, L. Y., Xajil-Ramos, L. Y., Xajil-Ramos, L. Y., Xajil-Ramos, L. Y., Gándara-Mireles, J. A., Gándara-Mireles, J. A., . . . Lou-Meda, R. Impact of CYP3A5 1* and 3* single nucleotide variants on tacrolimus pharmacokinetics and graft rejection risk in pediatric kidney transplant patients. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Xajil-Ramos, Lesly Yanira, et al. Impact of CYP3A5 1* and 3* Single Nucleotide Variants on Tacrolimus Pharmacokinetics and Graft Rejection Risk in Pediatric Kidney Transplant Patients. Frontiers Media S.A.

MLA (9th ed.) Citation

Xajil-Ramos, Lesly Yanira, et al. Impact of CYP3A5 1* and 3* Single Nucleotide Variants on Tacrolimus Pharmacokinetics and Graft Rejection Risk in Pediatric Kidney Transplant Patients. Frontiers Media S.A.